Medication Update – Apomorphine (Movapo)

We are pleased to inform you that apomorphine (MOVAPO) has received a positive recommendation by CADTH, the Canadian Agency for Drugs and Technologies in Health. Parkinson Canada filed a patient evidence submission for the review process that was informed by a survey from nearly 900 people with Parkinson’s and caregivers, as well as interviews with … Read more

Tanya Good joins Parkinson Canada in Alberta

Parkinson Canada is pleased to announce that Tanya Good has joined the national health charity as Manager, Alberta. She leads all aspects of Parkinson Canada’s Alberta operations, including program and service delivery, local events and community fundraising. Tanya will play a key role in expanding Parkinson Canada’s services to Albertans.  Opening an office in Calgary … Read more

Easing the pain of Parkinson’s

Pain is a constant companion for as many as 10 percent of people with Parkinson’s disease. Unfortunately, most of them can’t tolerate the sleepiness and confusion regular pain medications induce. That’s why Dr. Susan Fox, a Toronto neurologist and professor at the University of Toronto, is investigating a different source of pain relief. Fox is … Read more

Improving damage detection in the brain

A pair of proteins, whose malfunction is associated with Parkinson’s disease, normally work together to fulfill valuable housekeeping chores within the body. They keep brain cells healthy, for example, by discarding dead or dying material inside them. But these proteins have to be tightly controlled, because if they “help” too much, they can become harmful. … Read more